HRH4

Chr 18

histamine receptor H4

Also known as: AXOR35, BG26, GPCR105, GPRv53, H4, H4R, HH4R

HRH4 encodes histamine receptor H4, a G protein-coupled receptor that mediates chemotaxis of immune cells to sites of inflammation and influences release of proinflammatory cytokines in response to histamine. Pathogenic variants in HRH4 cause autosomal recessive primary immunodeficiency with recurrent infections and allergic manifestations. The gene shows low constraint against loss-of-function variants, consistent with autosomal recessive inheritance.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
10
Pubs (1 yr)
36
P/LP submissions
0%
P/LP missense
1.44
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryHRH4
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
34 unique Pathogenic / Likely Pathogenic· 59 VUS of 102 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.44LOEUF
pLI 0.000
Z-score 0.38
OE 0.89 (0.571.44)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.47Z-score
OE missense 0.91 (0.801.03)
180 obs / 198.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.89 (0.571.44)
00.351.4
Missense OE0.91 (0.801.03)
00.61.4
Synonymous OE1.21
01.21.6
LoF obs/exp: 12 / 13.5Missense obs/exp: 180 / 198.5Syn Z: -1.44
DN
0.76top 25%
GOF
0.72top 25%
LOF
0.2776th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

102 submitted variants in ClinVar

Classification Summary

Pathogenic33
Likely Pathogenic1
VUS59
Likely Benign5
33
Pathogenic
1
Likely Pathogenic
59
VUS
5
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
33
0
33
Likely Pathogenic
0
0
1
0
1
VUS
0
53
6
0
59
Likely Benign
0
5
0
0
5
Benign
0
0
0
0
0
Total05840098

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

HRH4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →